A genetic approach to evaluation of short stature of undetermined cause

Publication date: Available online 1 February 2018 Source:The Lancet Diabetes & Endocrinology Author(s): Philip G Murray, Peter E Clayton, Steven D Chernausek Short stature is a common presentation to paediatric endocrinologists. After exclusion of major endocrine or systemic disease, most children with short stature are diagnosed based on a description of their growth pattern and the height of their parents (eg, familial short stature). Height is a polygenic trait and genome-wide association studies have identified many of the associated genetic loci. Here we review the application of genetic studies, including copy number variant analysis, targeted gene panels, and whole-exome sequencing in children with idiopathic short stature. We estimate 25–40% of children diagnosed with idiopathic short stature could receive a molecular diagnosis using these technologies. A molecular diagnosis for short stature is important for affected individuals and their families and might inform treatment decisions surrounding use of growth hormone or insulin-like growth factor 1 therapy.

Source: The Lancet Diabetes and Endocrinology - February 1, 2018 Category: Endocrinology Source Type: research